CIK 0001644963 · Non-accelerated filer<br>Smaller reporting company
AVENUE THERAPEUTICS, INC.
Sign in to watch- Ticker
- ATXI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474113275
- Phone
- 781-652-4500
- Business address
- 1111 KANE CONCOURSE, SUITE 301, BAY HARBOR ISLANDS, FL, 33154
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Other events
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 1,000 shares at $4.52 ($4,520)
- 8-K Event Delisting notice · Executive or director change
- 4 Open-market buy Director bought 2,000 shares at $5.11 ($10,220)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 5,000 shares at $5.46 ($27,300)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- 4 Open-market buy Director bought 8,850 shares at an average $5.88 ($52,045)
- 4 Open-market buy Director bought 650 shares at $5.91 ($3,842)
- 4 Open-market buy Director bought 10,000 shares at an average $5.90 ($58,999)
- DEFA14A Proxy Proxy Materials
- SC 13G Stake Amended Statement of Ownership
Page 16 of 22 · 424 filings